Paolo Baroldi

Paolo Baroldi is currently the Chief Medical Officer at Bloom Science, Inc. with a focus on COVID-19, oncology, and ophthalmology. With a background in various pharmaceutical companies such as Evergreen Pharmaceuticals, Vanda Pharmaceuticals, and Supernus Pharmaceuticals, Paolo has extensive experience in clinical development and regulatory affairs. Paolo also taught Bioscience Regulatory Affairs at Johns Hopkins University and held positions in global clinical pharmacology at Novartis. Paolo's academic background includes a Medical Degree and PhD in Clinical Pharmacology from Università degli Studi di Milano.